Overall rank by patents
#49,862
of 49,997 tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 10 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica).
The verdict
According to USPTO PatentsView, Q.ant ranks #49,862 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 10 technology areas.
USPTO PatentsView assignee plate
Corpus R49862 · Foreign Corporation #49,862 · 5 grants
GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Python Medical, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Q ANT · this assignee
49 score
3D Lighting… · lowest
7 score
What this shows Q.ant's Innovation Score is 48.6/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Q.ANT GMBH is a focused PatentsView assignee: 10 CPC subclasses with 60% of grants classified under G02F (Optical Devices OR Arrangements FOR THE Control OF Light BY Modification OF THE Optical Properties OF THE Media OF THE Elements Involved THEREIN; Non-linear OPTICS; Frequency-changing OF LIGHT; Optica). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2024. By volume, Q.ant sits between Python Medical, Inc. and Qbas Co., Ltd..
Q.ANT GMBH shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Python Medical, Inc.
5 patents
Q-ba-maze Inc.
5 patents
Q-Genetics ApS
5 patents
Q-state Biosciences, Inc.
5 patents
Q1 Nanosystems Corporation
5 patents
QA1 Precision Products, Inc.
5 patents
Qardio, Inc.
5 patents
Qbas Co., Ltd.
5 patents
Q.ANT GMBH
5 patents
What this shows Q.ANT holds 5 patents at rank #49,863, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #49,863 in granted patent volume.
Other assignees with the most granted patents in QANT's primary technology class.
Q.ant's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 2 | 40.0% |
| 2024 | 1 | 20.0% |
| 2025partial year | 2 | 40.0% |
Top 10 of 10 technology areas
Overall rank by patents
#49,862
of 49,997 tracked assignees
48.6 out of 100
What to do with this data
Q.ANT GMBH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.